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Background: The mammalian cochlea receives and analyzes sound at specific places along the cochlea coil,
commonly referred to as the tonotopic map. Although much is known about the cell-level molecular defects
responsible for severe hearing loss, the genetics responsible for less severe and frequency-specific hearing loss
remains unclear. We recently identified quantitative trait loci (QTLs) Hfhl1 and Hfhl2 that affect high-frequency
hearing loss in NIH Swiss mice. Here we used 2f1-f2 distortion product otoacoustic emissions (DPOAE)
measurements to refine the hearing loss phenotype. We crossed the high frequency hearing loss (HFHL) line of NIH
Swiss mice to three different inbred strains and performed linkage analysis on the DPOAE data obtained from the
second-generation populations.
Results: We identified a QTL of moderate effect on chromosome 7 that affected 2f1-f2 emissions intensities (Hfhl1),
confirming the results of our previous study that used auditory brainstem response (ABR) thresholds to identify
QTLs affecting HFHL. We also identified a novel significant QTL on chromosome 9 (Hfhl3) with moderate effects on
2f1-f2 emissions intensities. By partitioning the DPOAE data into frequency subsets, we determined that Hfhl1 and
Hfhl3 affect hearing primarily at frequencies above 24 kHz and 35 kHz, respectively. Furthermore, we uncovered
additional QTLs with small effects on isolated portions of the DPOAE spectrum.
Conclusions: This study identifies QTLs with effects that are isolated to limited portions of the frequency map. Our
results support the hypothesis that frequency-specific hearing loss results from variation in gene activity along the
cochlear partition and suggest a strategy for creating a map of cochlear genes that influence differences in hearing
sensitivity and/or vulnerability in restricted portions of the cochlea.
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Mammals discriminate sound energy over a wide range
of intensities and frequencies due to adaptations that
have produced a cochlea that amplifies and attenuates
input in a non-linear and frequency-specific manner.
The astounding versatility of the mammalian cochlea is
possible because its physiological and biomechanical
characteristics change from the base to the apex to
produce a gradient of frequency-specific regions referred
to as the tonotopic map [1]. The mammalian outer hair
cells (OHCs), which are capable of changing length in* Correspondence: kellerjm@nidcd.nih.gov
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permits unrestricted use, distribution, and reprodresponse to mechanical forces that deflect their stereocilia
and alter their membrane potential, play a primary role in
tonotopy [2,3]. As might be expected, changes in a number
of OHC characteristics parallel changes in frequency sensi-
tivity. For example, OHCs are longer and have longer
stereocilia at the apex of the cochlea than at the base [1].
Additionally, the expression of genes coding for ion chan-
nels and other molecules thought to be important in OHC
function exhibit tonotopic gradients [4]. Graded changes
in ion channel structure or composition provides the most
parsimonious explanation for the discovery that the con-
ductance of the cochlear mechanoelectrical transduction
(MET) channels changes tonotopically, at least in turtles
[5]. Perturbations in the expression or function of a num-
ber of the genes necessary for OHC activity havetes Government; Title U.S.C 5 105 provides that copyright protection is not
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responsible for coordinating and differentiating expression
of these genes along the mammalian organ of Corti are yet
to be determined.
Many loci have been linked to hearing deficits in humans
(http://hereditaryhearingloss.org/) and mice (http://hearin-
gimpairment.jax.org/). However, many other loci probably
remain undiscovered, including those that contribute to
tonotopy. Although evidence suggests that the primary
morphogen Sonic hedgehog (Shh) plays a key role in initiat-
ing tonotopic development by establishing the gradient of
Gli transcription factors that first defines the basal and ap-
ical identities of the cochlear duct [7], the downstream
molecules responsible for establishing and maintaining the
proper physiological characteristics required for tonotopy
still need to be determined. Identifying the genes respon-
sible for this phenomenon may be necessary to understand
less severe, but more common, forms of human hearing im-
pairment, including presbycusis and other forms of hearing
loss that preferentially affect particular frequency ranges.
Despite recent advances, human genome wide association
studies (GWAS) remain much less powerful for detecting
genes involved in complex, multifactorial diseases than for
diseases with simple Mendelian expression, indicating that
mouse models may be critical for identifying genes related
to tonotopy.
NIH Swiss mice are genetically heterogeneous [8] and
have significantly variable 32 kHz ABR thresholds [9].
Recently, we sought to determine the genetic basis for hear-
ing variation in NIH Swiss outbred mice via selective breed-
ing and linkage mapping [10]. We were able to locate at
least two QTLs (Quantitative Trait Locus), Hfhl1 on
chromosome 7 and Hfhl2 on chromosome 8, that affect
32 kHz ABR thresholds but not lower frequency thresholds
[10]. The results of that study suggested that the line of
mice selected for high-frequency hearing impairment would
be useful for studying genes that differentially affect the base
and the apex of the cochlea. Here, we performed linkage
mapping using additional NIH Swiss crosses to verify the
previously discovered QTLs. We also made use of the quan-
titative data obtained from DPOAE measurements to ex-
pand our analysis of the genetics of the novel high-
frequency hearing loss phenotype. Finally, since functionally
and developmentally related components of a biological
feature are expected to be more integrated than less related
components [11], we expected topologically proximal
regions of the organ of Corti to be more integrated than
more distally spaced regions. So, we examined the relation-
ship between DPOAE intensities produced in response to a
range of input frequencies across the murine auditory
spectrum (i.e. produced at different tonotopic locations).
We hypothesized that the developmental and structural
relationships between different cochlear regions would
translate to functional relationships that would bedetectable as correlations in the DPOAE data that vary
based on relative tonotopic position and are influenced by
genetic differences within the test populations.
Results
To obtain a preliminary assessment of high-frequency
hearing, we recorded 32 kHz ABR thresholds for HFHL,
C3HeB/FeJ, CBA/CaJ, C57BL/6J, C3H-N2, CBA-F2, and
C57-F2 mice at 4–8 weeks of age (Figure 1A, Table 1). As
expected, the HFHL mice had 32 kHz ABR thresholds
significantly higher than all other groups (p< 0.0001).
However, although the C3H-N2 and CBA-F2 populations
appear to have higher hearing thresholds than the re-
spective normal-hearing parental lines, these differences
were not statistically significant. Similarly, the C57-F2
population had ABR thresholds that were not different
from the parental C57BL/6J strain. On the other hand,
variation in hearing thresholds was greater for the C3H-
N2 and CBA-F2 populations than for their respective
normal hearing parental strains (p< 0.0001) but not the
HFHL line.
To investigate the genetic basis underlying differences in
hearing in the C3H-N2 (n= 305), CBA-F2 (n= 297), and
C57-F2 (n= 333) populations, we first plotted the
frequency distributions of the 32 kHz ABR thresholds for
each population. The 32 kHz ABR threshold distributions
(Figure 1B-D) vary considerably, suggesting that the
genetic factors that contribute to the differences in hearing
within a population also vary between populations. As
shown previously ([10]; reproduced in Figure 1B), the dis-
tribution of the C3H-N2 population is highly skewed and
is best fit using a model for the sum of two Gaussian dis-
tributions (R2 = 0.97, n = 306). The skewing of the C3H-N2
distribution suggests that there is at least one allele influ-
encing 32 kHz thresholds that has a relatively large effect
in that population. In contrast, the 32 kHz frequency dis-
tribution of the CBA-F2 population is Gaussian (R2 = 0.96,
n = 294) with a mean of 40± 5.97 (Figure 1C), suggesting
that many genes of small and approximately equal effect
influence 32 kHz thresholds in the CBA-F2 population.
Finally, the distribution of the C57-F2 population
(Figure 1D) appears to have a bimodal distribution with
means at 37.9 ± 6.71 (R2 = 0.76, n = 238) and 70.7 ± 7.72
(R2 = 0.85, n = 82). The bimodal frequency distribution of
the C57-F2 population suggests that there is a single locus
responsible for a substantial difference in mean 32 kHz
thresholds in that population.
To evaluate outer hair cell function and obtain quantita-
tive phenotypic data across the entire frequency range of
the cochlea, we measured distortion product otoacoustic
emissions (DPOAEs). Average noise-floor-corrected emis-
sions spectra for the four parental strains (C3HeB/FeJ,
CBA/CaJ, C57BL/6J, and HFHL) are shown in Figure 2A.
Eight-week-old C3HeB/FeJ and CBA/CaJ mice have robust
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Figure 1 Auditory brainstem responses. (A) ABR thresholds in dB SPL for 32 kHz pure tone stimuli in the parental and second-generation (N2
and F2) populations. (B-D) Threshold distributions for (B) C3H-N2, (C) CBA-F2, and (D) C57-F2 populations. (B) The C3H-N2 frequency distribution
was produced using data presented previously [10] and is reproduced here for clarification and presentation purposes. This distribution is best fit
by the sum of two Gaussian distributions (Goodness-of-fit R2 = 0.96, n = 306). (C) The CBA-F2 frequency distribution was fitted using a Gaussian
distribution (Goodness-of fit R2 = 0.96, n = 294). (D) The C57-F2 frequency distribution appears to be bi-modal but only the first peak of the curve
could be fitted initially (Goodness-of-fit R2 = 0.76, n = 320). When the data from individuals with 32 kHz ABR thresholds 60 dB SPL or greater was
analyzed separately, the second peak fit a Gaussian distribution (Goodness-of-fit R2 = 0.85, n = 82).
Keller and Noben-Trauth BMC Genetics 2012, 13:32 Page 3 of 14
http://www.biomedcentral.com/1471-2156/13/322f1-f2 emissions at all frequencies tested. Although
C57BL/6J mice do appear to have slightly lower 2f1-f2
emissions at all frequencies than C3HeB/FeJ and CBA/CaJTable 1 High Frequency Phenotypes by Line or Cross
32 kHz ABR HFEA
Line/Cross Age (wks) n mean SD mean SD
HFHL-F12 8 12 84.6 8.6 2.6 2.0
C3HeB/FeJ 8–10 17 42.4 3.6 17.9 3.6
CBA/CaJ 8 12 35.8 4.7 18.6 4.0
C57BL/6J 8 12 50.4 16.4 13.4 6.9
NIHxC3H F1 8 21 37.4 7.0 19.3 2.4
NIHxC3H N2 8 306 46.7 12.4 11.2 6.4
NIHxCBA F2 8 294 42.9 9.0 16.8 6.5
NIHxC57 F2 8 320 47.4 15.5 14.9 8.6
wks, weeks; n, number of animals tested; SD, standard deviation; HFEA, High
Frequency Emissions Average.mice (probably the result of a single C57BL/6J mouse that
had no discernable emissions at any frequency), they still
appear to have relatively normal 2f1-f2 emissions at
8 weeks of age. In agreement with our previous results, the
HFHL mice have 2f1-f2 emissions approximately equal to
those of the C3HeB/FeJ mice until the f2 input frequency
reaches about 25 kHz, but have poor emissions beyond
25 kHz and basically no emissions when the f2 input is
above 30 kHz.
The DPOAE graphs and high frequency emission
average (HFEA) values for the three crosses further
demonstrate the heritability of the HFHL phenotype
(Figure 2B-D, Table 1). As expected for a heritable trait,
the HFEA values for the C3H-N2 and the CBA-F2 popula-
tions are intermediate to those of their respective parental
lines (Table 1) and the DPOAE spectra exhibit a similar
relationship (Figure 2B, C). Additionally, the NIHxC3H-F1
population has an average DPOAE spectrum that is ap-
proximately equal to the C3HeB/FeJ spectrum (Figure 2B),
A B
DC
Figure 2 Distortion product otoacoustic emissions. Average DP-grams for mice (8–10 weeks old) in response to 5–55 kHz f2 inputs of 65 dB
intensity. Distortion product amplitudes have been corrected to account for differences in noise floors between samples. (A) DP-grams of mice from
each of the 4 parental strains: C3HeB/FeJ (n= 17), CBA/CaJ (n= 12), C57BL/6J (n= 12), NIH Swiss HFHL (n= 12). (B) DP-grams for the parental, F1 (n= 8),
and N2 (n= 306) populations for the NIH Swiss HFHL x C3HeB/FeJ cross. (C-D) DP-grams for the parental and F2 populations for the (C) NIH Swiss
HFHL x CBA/CaJ (n= 294) and (D) NIH Swiss HFHL x C57BL/6J crosses (n= 320). DPgrams of parental strains were redrawn in (B-D) for comparison.
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to recessive alleles. Interestingly, the C57-F2 population
does not follow this pattern and has high-frequency hear-
ing approximately equal to or slightly better than that of
the C57BL/6J parental line (Figure 2D, Table 1). The C57-
F2 population also appears to have better low-frequency
hearing than either parental line, perhaps suggesting gene
interactions.
The emissions intensities within the C3H-N2 and CBA-
F2 populations appear to be highly variable at frequencies
above 30 kHz (Data not shown). A few individuals from
each cross exhibit substantially reduced emissions at
frequencies as low as 20 kHz. At frequencies slightly
higher than 30 kHz, the individual spectra become more
variable, with many spectra lying obviously above the
mean and others clearly below. The variation in the
distributions becomes less pronounced at frequencies
above about 45 kHz, probably due to an increase in noise
during DPOAE measurement. Based on the variation in
the DPOAE spectra, for each mouse we averaged the
noise-floor-corrected 30–44 kHz DPOAE values in
response to 65 dB SPL f2 input to create the variable,
HFEA, that represented the quality of a mouse’s high-
frequency emissions and was amenable to QTL analysis.Correlations in DPOAE data
To determine if correlations between emissions intensities
produced by different frequencies differed depending on
the strain, we evaluated the correlations between 2f1-f2
distortion product intensities independently for each
strain. Significant correlations between 2f1-f2 distortion
product intensities are present in all four parental popula-
tions (Additional file 1: Table S1, Additional file 2:
Table S2, Additional file 3: Table S3, Additional file 4:
Table S4). For the C3HeB/FeJ and CBA/CaJ strains, most
of the significant correlations occur between 23–48 kHz
frequencies (Additional file 2: Table S2, Additional file 3:
Table S3). In both of these strains, the number of signifi-
cant correlations exceeds the number expected by chance
(C3HeB/FeJ: χ2 = 15.4, p< 0.0001; CBA/CaJ: χ2 = 44.1, p
< 0.0001). In contrast, there were far fewer significant cor-
relations between 2f1-f2 distortion product intensities in
the HFHL mice. Furthermore, although initial examin-
ation of the C57BL/6J data suggested that a high percent-
age of the 2f1-f2 distortion product intensities were
strongly correlated, these significant correlations were al-
most entirely the result of a C57BL/6J outlier that had no
detectable 2f1-f2 distortion products for any f2 frequency.
Since it is well documented that C57BL/6J mice have
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until at least 3 months of age (see e.g. [12]), we eliminated
the data from this outlier and reran the analysis for the
C57BL/6J strain (Additional file 4: Table S4). Both the
C57BL/6J strain and the HFHL line had fewer significant
correlations (108 and 73, respectively) than the 127 signifi-
cant correlations that are expected by chance due to the
large number of tests (p> 0.05).
Principal components analysis of DPOAE
To reduce the noise and complexity of the DPOAE spectra
and produce new variables that best explain the variance in
the population, we performed Principal Component Ana-
lysis on the C3H-N2 DPOAE data (see Figure 3). The first
5 principal components explain about 53% of the variation
in DPOAE data in the population. The first principal com-
ponent (PC1) explains about 25% of the variation in
DPOAE and has positive loadings for each of the 51 vari-
ables (the 51 2f1-f2 distortion product intensities that were
recorded for 65 dB SPL f2 input intensities across a range
of frequencies), so PC1 may be considered a measure of the
overall magnitude of DPOAEs (Figure 3). PC2 explains ap-
proximately 11% of the variation in DPOAE and has posi-
tive loadings for most of the variables representing
frequencies below 34 kHz and negative loadings for the
variables representing frequencies above 35 kHz (Figure 3).
Thus, PC2 seems to be a measure of reduced high-fre-
quency emissions relative to low-frequency emissions and
may serve as a good indicator of HFHL. PC3 explains ap-
proximately 9% of the variation in DPOAE and hasFigure 3 Loading of principal components 1 and 2. Loading of the first
of the f2 stimulus frequency. The first component (PC1) has all positive load
emissions. The second component (PC2) has positive loading for low frequ
measure of the contrast between the magnitude of high frequency emissionegative loadings for the variables representing 22–35 kHz
frequencies and positive loadings for most other variables,
so it seems to be a measure of reduced emissions at inter-
mediate frequencies. PC4 and PC5 each account for only
about 4% of the variation in DPOAE and appear to repre-
sent more complex contrasts. PC4 has positive loadings for
the variables representing 33–42 kHz frequencies, but nega-
tive loadings for most other variables, indicating it is a
measure of good intermediate frequency emissions. The
loadings for PC5 seem to suggest that it is primarily an
indicator of increased low frequency emissions in indivi-
duals with poor intermediate frequency emissions.
Genetic analysis
Although 32 kHz ABR thresholds from the C3H-N2
population were used previously for QTL analysis [9], we
reasoned that since the HFHL defect appears to be
related to OHC function the DPOAE data might be
more valuable than the ABR thresholds for identifying
loci responsible for hearing impairment in our popula-
tions. We therefore used PC1 in a QTL analysis to iden-
tify genes influencing differences in overall magnitude of
DPOAE in our C3H-N2 population (Table 2). The pre-
liminary genome-wide QTL scan using the PC1 values
identified two significant QTLs. A highly significant QTL
(LOD=4.6) that accounts for about 7% of the variation in
PC1 lies near rs6228386 on chromosome 7. The second
significant QTL (LOD=3.1) lies near rs3709825 on
chromosome 9 and accounts for about 5% of the variation
in PC1. Furthermore, suggestive QTLs accounting fortwo principal components for DPOAE spectra are plotted as a function
ings, indicating that it is a measure of the overall magnitude of
encies and negative loading for high frequency, indicating that it is a
ns and low frequency emissions.
Table 2 QTL influencing DPOAE in C3H-N2 mice
Trait Marker Chr LRS (LOD) p Value Effect
PC1 rs6181382 6 8.5 (1.84) 0.00353 3%
rs6228386 7 21.2 (4.61) <0.00001 7%
rs3709825 9 14.1 (3.06) 0.00017 5%
rs3023429 15 7 (1.51) 0.00813 2%
rs6358426 18 8.7 (1.89) 0.00316 3%
HFEA rs13477127 3 7.7 (1.67) 0.00547 3%
rs6228386 7 24.2 (5.25) <0.00001 8%
rs13480323 9 19.4 (4.21) 0.00001 6%
rs3023429 15 7.9 (1.97) 0.00482 3%
rs6358426 18 9.1 (1.97) 0.00255 3%
5–9 kHz rs3658401 5 12.7 (2.75) 0.00037 4%
rs13480208 9 11.9 (2.58) 0.00057 4%
rs3698545 14 11.5 (2.49) 0.00070 4%
10–14 kHz rs13477504 3 7 (1.51) 0.00819 2%
rs13479082 6 8.5 (1.84) 0.00347 3%
20–24 kHz gnf01.037.906 1 7.2 (1.56) 0.00723 2%
rs3724711 7 6.8 (1.47) 0.00901 2%
rs6207781 9 8.6 (1.87) 0.00342 3%
25–29 kHz rs13476259 1 7.5 (1.63) 0.00634 3%
rs6181382 6 7.5 (1.63) 0.00626 3%
rs3724711 7 16.4 (3.56) 0.00005 5%
rs6207781 9 9.6 (2.08) 0.00199 3%
30–34 kHz rs13478952 6 7.3 (1.58) 0.00674 2%
rs3724711 7 23.8 (5.16) <0.00001 8%
rs13480323 9 7.2 (1.56) 0.00746 2%
35–39 kHz rs3688780 3 11.4 (2.47) 0.00074 4%
rs6160140 7 16.9 (3.67) 0.00004 6%
rs13480323 9 18.4 (3.99) 0.00002 6%
rs3023429 15 8.1 (1.76) 0.00432 3%
rs6358426 18 7.3 (1.58) 0.00683 2%
40–44 kHz rs3688780 3 11.1 (2.41) 0.00087 4%
rs13477669 4 7.5 (1.63) 0.00603 3%
rs6228386 7 13.8 (2.99) 0.00020 5%
rs13480323 9 17.1 (3.71) 0.00004 6%
rs3023429 15 8 (1.74) 0.00473 3%
45–49 kHz rs13482141 14 9.4 (2.04) 0.00216 3%
rs3023429 15 8.7 (1.89) 0.00317 3%
50–55 kHz rs3688780 3 10 (2.17) 0.00155 3%
rs13459177 15 7.6 (1.65) 0.00599 3%
Chr, chromosome; HFEA, High Frequency Emissions Average.
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15, and 18.
Although the results of the QTL analysis using PC1
were interesting, PC1 appears to be related to the magni-
tude of the 65 dB DPOAE spectra across all frequencies,while the most intriguing feature of the hearing loss in our
populations is its frequency specificity. Therefore, we
elected to search for QTLs using PC2, PC3, and HFEA,
which subdivided the frequency spectra. No significant
QTLs were detected for PC2 and PC3, but the analysis of
HFEA revealed 2 highly significant QTLs (Table 2). A
highly significant QTL (LOD=5.2) that accounted for
about 8% of the variation in HFEA values was located near
rs6228386 on chromosome 7. Another QTL (LOD=4.2)
accounted for about 6% of the variation in HFEA and was
located on chromosome 9 near rs13480323. Additional
loci suggestive of QTLs were identified on chromosomes
3, 15, and 18. These putative QTLs were each responsible
for about 3% of the variation in HFEA values.
To determine whether different genes affect the
emissions values depending on the frequency evaluated,
we decomposed the 65 dB 2f1-f2 distortion product inten-
sity data and created a series of average DPOAE intensities
calculated from frequency ranges of approximately 5 kHz
each (5–9 kHz, 10–14 kHz, 15–19 kHz, 20–24 kHz,
25–29 kHz, 30–34 kHz, 35–39 kHz, 40–44 kHz,
45–49 kHz, and 50–55 kHz) of the 65 dB DPOAE
frequency spectra. Then, we ran marker regressions on the
average DPOAE values calculated for the ten 5 kHz seg-
ments. A number of suggestive and significant QTLs were
detected (Table 2). All of these QTLs affected only a subset
of the 5 kHz segments. However, the QTLs generally
appeared to affect multiple segments that tended to be
clustered together (Figure 4). A QTL on chromosome 7
near rs6160140 significantly affected the segments encom-
passing the entire 25–44 kHz frequency range and a QTL
on chromosome 9 near rs13480323 significantly affected
segments in the 35–44 kHz frequency range. Loci on
chromosome 3 and 15 were suggestive of QTLs with
effects on the 35–55 kHz frequency range.
To more accurately identify the locations of the two
most significant QTLs affecting DPOAEs, we performed
composite interval mapping for HFEA on both chromo-
some 7 and chromosome 9 (Figure 5). In these analyses,
we included the highly significant locus located on the
opposite chromosome as background. The QTL on
chromosome 7 encompasses much of the chromosome
and spans the Hfhl1 interval that we detected previously
using ABR thresholds [10]. The QTL on chromosome 9
appears to lie at approximately 40 ± 10 cM.
Although we were unable to perform genome-wide QTL
mapping for the CBA-F2 and C57-F2 populations, we
were able to genotype them at a few loci for association
mapping. To confirm our earlier analysis, the mice from
the CBA-F2 and C57-F2 populations were genotyped at
loci on chromosomes 7 and 9 that are located near the
QTLs that we detected in the C3H-N2 population (see
Table 3). Furthermore, we genotyped each population at
loci on chromosome 8 that are located near Hfhl2, a locus
Figure 4 Frequency specificity of C3H-N2 QTLs. The heights of the vertical bars indicate the LOD scores calculated for QTLs that affect one or
more of the 10 segments into which the DPOAE spectrum was divided. Only those QTL that were first identified in the marker regression analyses of
the C3H-N2 population using PC1 or HFEA as the quantitative trait are shown. Each color represents a particular locus and the number given for the
QTL indicates the chromosome on which the QTL was detected. Dashed lines indicate the permutation derived genome-wide significance levels for
suggestive, significant, and highly significant linkage. No bars are shown in cases for which the p value of the LOD score exceeded 0.05.
Figure 5 Interval maps of HFEA QTLs on chromosomes 7 and 9. Interval mapping plots for QTL affecting the HFEA trait on (A) chromosome
7 and (B) chromosome 9 in the C3H-N2 population. Dashed lines indicate the permutation derived genome-wide significance levels for
suggestive, significant, and highly significant linkage. Bars indicate the 1.5 LOD support interval.
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Table 3 Loci Genotyped in C57-F2 and CBA-F2 Crosses




C57-F2 7 D7MIT83 59.0 rs13479325*-rs6279696
8 rs13479840 78.3 rs3667255-rs6296891*
rs13479929 97.3 rs3661882*
9 rs13480341 90.8 rs13480325*-rs3088463







CBA-F2 7 rs8255275 46.0 rs6228386-rs6160140
rs3680765 56.6 rs6160140*-rs13479325*
rs3719301 64.2 rs13479325-rs6279696
8 rs13479840 78.3 rs3667255-rs6296891*
rs13479916 94.3 rs6296891-rs3661882*
9 rs13480313 84.0 rs13480208-rs13480323*






* SNP is within 5 Mbp of the SNP evaluated in the C57-F2 or CBA-F2
population. Chr, chromosome; Mbp, mega base pairs.
Table 4 QTL influencing hearing in CBA-F2 and C57-F2
mice
Line Trait Chr Marker LRS (LOD) p Value Effect
C57-F2
32 kHz ABR 10 rs13480621 280.2 (60.7) <0.00001 57%
HFEA 10 rs13480621 311.6 (67.6) <0.00001 63%
7 D7MIT83 10.2 (2.2) 0.00614 2%
PC1 10 rs13480621 259.9 (56.4) <0.00001 56%
PC2 10 rs13480621 25.8 (5.6) <0.00001 8%
PC3 10 rs39365220 12.0 (2.6) 0.00250 4%
5–9 kHz 10 rs3089912 19.2 (4.2) 0.00007 6%
10–14 kHz 10 rs13480621 20.4 (4.4) 0.00004 6%
15–19 kHz 10 rs13480621 35.3 (7.7) <0.00001 11%
20–24 kHz 10 rs13480621 143.0 (31.0) <0.00001 36%
25–29 kHz 10 rs13480621 202.6 (43.9) <0.00001 47%
30–34 kHz 10 rs13480621 250.1 (54.3) <0.00001 55%
35–39 kHz 10 rs13480621 290.1 (62.9) <0.00001 60%
7 D7MIT83 11.4 (2.5) 0.00336 2%
40–44 kHz 10 rs13480621 176.2 (38.2) <0.00001 43%
45–49 kHz 10 rs13480621 178.1 (38.6) <0.00001 22%
50–55 kHz 10 rs13480621 87.8 (19.0) <0.00001 24%
CBA-F2
HFEA 7 rs3680765 19.7 (4.27) 0.00005 7%
9 rs13480313 10.9 (2.4) 0.00425 4%
PC1 7 rs3680765 18.5 (4.0) 0.00010 6%
PC3 7 rs3719301 10.9 (2.4) 0.00428 4%
35–39 kHz 7 rs3680765 22.4 (4.9) 0.00001 7%
40–44 kHz 7 rs3680765 13.4 (2.9) 0.00122 5%
9 rs13480313 11.0 (2.4) 0.00415 4%
45–49 kHz 7 rs3680765 15.1 (3.3) 0.00053 5%
50–55 kHz 7 rs8255275 11.4 (2.5) 0.00346 4%
Chr, chromosome; HFEA, High Frequency Emissions Average.
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previous study using NIH Swiss mice (Table 3). Finally, we
genotyped both populations at loci all along chromosome 10
in order to account for effects of the Cdh23ahl mutation in
the C57-F2 cross (Table 3).
We detected significant QTLs on both chromosome 7
and chromosome 9 in the CBA-F2 population, confirm-
ing the results of the C3H-N2 population (Table 4). We
also detected a chromosome 7 QTL in the C57-F2 popu-
lation. However, its effects were small, probably because
of the highly significant QTL of large effect that is
located on chromosome 10 (Table 4) that probably
represents the effect of the Cdh23ahl allele that is known
to be present in the C57BL/6J strain [13].
In addition to testing for single locus effects, we also tested
whether any two loci interacted to affect 32 kHz ABR
thresholds, HFEA, or PC1-3 in each of the populations. This
was done using very stringent conditions in order to reduce
the possibility that the large number of tests might givespurious positive results. Under these stringent criteria, no
significant interactions were detected in any of our
populations.
Discussion
In this study, we produced several crosses to investigate
the genetic basis of impaired high frequency hearing in the
HFHL line of mice. To fully explore the entire range
of hearing, we used a number of methods for quantifying
and dissecting the DPOAE data from our populations.
These methods produced different values that could be
used in QTL mapping. We detected a QTL on chromo-
some 7 (Hfhl1) and a QTL on chromosome 9 (Hfhl3) that
significantly affect hearing. Furthermore, our analysis
allowed us to refine the frequency ranges that these two
QTLs affect and to detect additional putative QTLs with
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ABR thresholds. The QTLs were scattered throughout the
genome, varied considerable in effect size, and appeared to
have frequency-specific effects in many cases.
QTL effects
Several SNPs on chromosome 7 were found to have
significant effects on hearing in the whole genome scan of
the C3H-N2 population. In general, these SNPs lie rela-
tively near one another on the chromosome and are con-
tained within the confidence interval of the rather broad
QTL peaks observed for each trait. These loci probably all
represent the same QTL on chromosome 7, although it is
possible that linked loci are involved. This presumptive
chromosome 7 QTL affected multiple measures of hearing
in both the C3H-N2 and CBA-F2 population and
accounted for as much as 8% and 7% of the observed vari-
ation in DPOAE, respectively. Although the effects were
much less noticeable in the C57-F2 population, it was
detected in that population as well, despite the potentially
confounding effects of the highly significant chromosome
10 QTL. The chromosome 7 QTL that we detected in this
study is in the same region as the Hfhl1 locus that we pre-
viously identified as being responsible for increased 32 kHz
ABR thresholds in both the HFHL line and in another line
of mice produced from the NIH Swiss stock [10]. Our
results confirm the effect of the Hfhl1 locus and confine its
effect to the 25–44 kHz region of the tonotopic map.
Several linked loci on chromosome 9 were found to sig-
nificantly affect a number of DPOAE values in the C3H-N2
population. These chromosome 9 loci, like those on
chromosome 7, probably all represent a single QTL (Hfhl3).
Although undetectable using ABR thresholds, Hfhl3
explains as much as 6% of the observed variation in the
DPOAE of the C3H-N2 population. Interestingly, our ana-
lysis indicates that the effect of Hfhl3 is restricted to the
35–44 kHz region of the tonotopic map. Although Hfhl3
was found to have moderate effects on multiple measures
of hearing in both the C3H-N2 and the CBA-F2 lines, the
single locus genotyped in the same region of chromosome 9
in the C57-F2 cross did not significantly affect hearing. This
could be due to reduced power to detect a QTL of
moderate effect in the presence of the chromosome 10
locus of large effect, or due to insufficient linkage between
the chromosome 9 SNP that was genotyped and the actual
locus affecting hearing, although the locus chosen is in the
middle of the confidence interval for the QTL in the C3H-
N2 population. Interestingly, in our previous study using
HFHL mice, a suggestive QTL influencing 32 kHz ABR
thresholds was detected at rs13480208 (at 55 Mbp on
chromosome 9, Build 34) in the HFHL-N2 population [10].
This is close to the location of the rs13480323 (at 84 Mbp)
and rs13480313 (at 88Mbp) SNPs that significantly affected
DPOAE in this study.The Hfhl1 and Hfhl3 loci only explain a portion of the
variation in high-frequency hearing observed in the
C3H-N2 and CBA-F2 populations. Additional loci of
small effect and epistasis probably account for much of
the remainder of the variation and may also explain the
severity of the hearing phenotype observed in our HFHL
line compared to the relatively mild phenotypes exhib-
ited in the C3H-N2 and CBA-F2 populations. By dividing
the frequency spectra of the C3H-N2 population into
smaller segments, we detected a number of additional
loci that potentially account for residual variation in the
C3H-N2 population, supporting the role of additional
loci in the HFHL phenotype. However, epistatic effects
probably play a role as well since abundant epistasis has
been documented in studies of a number of complex
traits [14-16]. Additional genotyping and an in-depth
analysis of epistasis in the CBA-F2 population could
greatly increase our understanding of the genetic archi-
tecture of the HFHL phenotype.
The QTL with the largest effect in the C57-F2 population
was on chromosome 10 near rs13480621. This QTL
accounted for over 50% of the variation in 32 kHz ABR
thresholds, HFEA, and PC1 in the C57-F2 population, but
was not detected in the other two crosses, suggesting that
the allele responsible segregated in the C57BL/6J P0 strain.
Given its location and the population in which it was
detected, the QTL on chromosome 10 near rs13480621 is
almost certainly the result of the Cdh23 locus that is known
to reside in the same region of chromosome 10. The
Cdh23ahl allele contributes to age-related hearing loss in
many inbred strains, including the C57BL/6J strain [13]
from which the C57-F2 population was produced.
The failure to detect a chromosome 7 QTL for ABR
thresholds in the C57-F2 population may simply be be-
cause the large effect of the chromosome 10 QTL
obscured its effects. Decreased power could also explain
the failure to detect QTL affecting 32 kHz ABR thresholds
in the CBA-F2 population. However, it is possible that the
CBA-F2 population possesses one or more genetic modi-
fiers that attenuate the effects of the reduced emissions
such that ABR thresholds are normal despite the reduced
emissions. Genetic background and genetic modifiers have
been found to attenuate the effects of a number of other
genes that affect hearing in mice [17]. We did not detect
any genetic interactions in this study, but the power to de-
tect them is low and we used stringent criteria to limit the
chance of detecting false positives.
Analysis of DPOAE spectra
In this study, the chromosome 7 QTL had a significant
effect on PC1, an indicator of the overall magnitude of
DPOAE, suggesting that the effects of Hfhl1 might not
be specific to high-frequency hearing. However, by divid-
ing the DPOAE into 5-kHz segment, we showed that the
Keller and Noben-Trauth BMC Genetics 2012, 13:32 Page 10 of 14
http://www.biomedcentral.com/1471-2156/13/32chromosome 7 QTL has no effect on frequencies below
20 kHz, but significantly affects DPOAEs between
25 kHz and 44 kHz. In fact, the effects of this QTL are
greatest for 30–39 kHz frequencies in all three of our
populations. Thus, it appears that this effect on PC1 is
primarily, if not completely, due to its effect on the high-
frequency portion of the spectrum. These results support
the frequency-specific role of Hfhl1 that the ABR data
suggested [10].
Our analysis using HFEA produced very similar results
to the analysis using PC1, supporting the validity of
using our somewhat arbitrary divisions of the DPOAE
spectra as quantitative traits for mapping. Dividing the
DPOAE spectra into segments for analysis of frequency-
specific QTLs is further validated by the results of the
correlation matrices of the DPOAE data which seem to
support our hypotheses that emissions intensities
produced in response to similar frequencies would be
more correlated than those produced in response to less
similar frequencies and that any alleles that decrease
hearing would reduce those correlations. By dividing the
emissions spectra, we found that different QTLs affected
emissions for different frequencies and that each only
affected a portion of the entire frequency spectrum (see
Table 2). These results should not be over-interpreted to
mean that the QTLs have discrete boundaries of expres-
sion in the cochlea or that they are active in specific
tonotopic regions only. The effects of these QTLs might
be detectable at particular frequencies because their
functions are less critical in seemingly unaffected
regions. However, the QTL boundaries could also be the
result of cochlear mechanics that accentuate hearing
deficits caused by those QTLs in certain regions, or
because our power to detect QTL effects is lower in
other cochlear regions.
It is somewhat surprising that our analysis did not
produce additional principal components for which we
could detect QTLs. This is particularly true for PC2
because the loadings indicated that it was a measure of
the contrast between an individual’s high-frequency and
low-frequency emissions, which would appear to best
describe the difference between HFHL and normal hearing
mice. However, perhaps there was simply insufficient
power to detect QTLs accounting for the variation
remaining in the population after the effects of PC1 were
removed. This would be especially true if PC2 was the
result of gene interactions.
Implications of analysis
The QTLs discovered in this study affect hearing via
attenuation of outer hair cell function in the base of the
cochlea. Dysmorphic hair bundles are common in
hearing loss [18] and the high frequency (basal) portion
of the cochlea seems to be most sensitive to damage.However, our previous morphological analyses did not
reveal abnormalities in the OHC hair bundles that
coincided with the onset of hearing loss [10]. Further-
more, mutations that affect hair bundle morphology
often produce severe or progressively worsening hearing
loss [10,18], while hearing loss is mild and relatively
stable in the NIH Swiss mice [10]. Similarly, mutations
that cause changes in endolymph composition can alter
the endocochlear potential and disrupt OHC function
by preventing mechano-electrical transduction [19].
Although ion concentrations were not tested, the endo-
cochlear potential is normal in NIH Swiss mice [10].
The early-onset, frequency-specific, and stable nature of
the hearing loss in NIH Swiss mice suggests that the loci
responsible for the phenotype may have a developmental
role that differs in importance along the cochlear duct. A
number of gene products have been shown to have a
graded expression along the organ of Corti [4], so it is
conceivable that a hypomorphic allele of one of these
genes might have a mild and frequency-specific effect
on hearing. On the other hand, theoretical modeling
demonstrated that cochlear shape might affect cochlear
response, at least for low frequency sounds [20]. Similarly,
it is possible that sensitivity to high-frequency sounds
could also be reduced by morphological or compositional
changes to the cochlear duct, tectorial membrane, or basi-
lar membrane since properties of these structures vary
tonotopically [1] and data suggests that cochlear function
is dependent on the mechanical properties of these coch-
lear structures [21]. Although gross morphology looked
normal in NIH Swiss mice [10], a more detailed analysis of
the relative size and shape as well as the molecular com-
position of these mechanically important components is
needed.
Although most mapping studies have used ABR
thresholds to identify QTLs responsible for differences
in hearing, others have used CAP thresholds [22,23],
and at least one previous study used DPOAE ampli-
tude [24]. Using either PC1 or HFEA to summarize
the DPOAE values we were able to detect a chromo-
some 7 QTL in all of our populations even though
we did not detect the QTL in either the NIHxC57-F2
population or the NIHxCBA-F2 population when ABR
thresholds were used. Similarly, Hfhl3 was only
detected when DPOAE values were used in the ana-
lysis. Furthermore, using DPOAE data we were able to
detect a number of putative loci of small effect that were
not recognized in our previous analysis using ABR
thresholds [10]. Most interestingly, by using DPOAE data,
refine the regions affected by Hfhl1 and Hfhl3 to limited
portions of the entire hearing spectrum. These results sug-
gest that DPOAE measurements coupled with QTL ana-
lyses should be given serious consideration when designing
experiments to investigate the molecular basis of hearing
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tect changes in hearing that are undetectable via ABR [25]
and DPOAE efficiently provides a more thorough map of
the cochlea than standard ABR protocols.
Conclusions
The non-progressive nature of the HFHL phenotype
makes the HFHL line of mice useful for studying the
genetic basis of frequency-specific hearing loss. By cross-
ing the HFHL line with different strains, we identified
two QTLs that affect emissions intensity over a limited
portion of the DPOAE spectrum and other putative loci
with similarly frequency-specific roles. These results
support the hypothesis that frequency-specific hearing
loss is the result of regionally specific gene activity along
the organ of Corti, and suggest that DPOAE measure-
ments combined with QTL mapping is a useful strategy
for determining the molecular factors underlying basal
to apical differences in hearing acuity.
Methods
Population
NIH Swiss mice were obtained from Charles River
Laboratories (Wilmington, MA). C3HeB/FeJ, CBA/CaJ
and C57BL/6J mice were obtained from The Jackson
Laboratory (Bar Harbor, Maine). High frequency hearing
loss (HFHL) mice were generated by selectively breeding
NIH Swiss mice that had good hearing at low frequency,
but poor high-frequency hearing. This was followed by
several (12–15) generations of inbreeding [10]. Although
the line was not entirely isogenic at this stage, the HFHL
phenotype was 100% penetrant with consistent expres-
sion in the HFHL line, so we considered the mice suffi-
ciently inbred at this point to begin our experiment. A
few F12-F15 HFHL mice were crossed to C3HeB/FeJ,
CBA/CaJ and C57BL/6J mice to create three different F1
populations. Several (HFHL x C3HeB/FeJ) F1 mice were
backcrossed to HFHL mice to produce a population of
[(HFHL x C3HeB/FeJ) x HFHL] N2 mice, hereafter
C3H-N2 mice (n = 306). Additionally, randomly selected
(HFHL x CBA/CaJ) F1 and (HFHL x C57BL/6J) F1 mice
were each intercrossed to produce two F2 populations,
hereafter designated CBA-F2 (n = 294) and C57-F2
(n = 320), respectively. The care and use of animals were
performed in compliance with the guidelines at the
National Institutes of Health and approved by the Animal
Care and Use Committee of the NINDS/NIDCD.
Auditory brain stem response measurements
Auditory-evoked brain stem response (ABR) measurements
were made with the Smart-EP version 10 (Intelligent
Hearing System, IHS; Miami, Florida) computer-aided
evoked potential system. The system was modified with
high frequency transducers to permit high frequencymeasurements. Electrodes were inserted subdermally at the
vertex of the cranium (active) and ventrolaterally to the
right (reference) and the left (ground) ears. The instrument
generated specific acoustic stimuli and then measured and
displayed the evoked brainstem responses of anesthetized
mice. A series of acoustic stimuli were delivered from the
high-frequency transducers to the right outer ear canal.
Mice were presented with a 32 kHz pure tone that was
varied in intensity from 100 dB SPL to 10 dB SPL in 5 dB
increments. Each intensity level was presented at a rate of
19.1 times/s for 350 sweeps. The lowest intensity producing
two consistent characteristic waveforms was recorded as
the 32 kHz ABR threshold.
Distortion product otoacoustic emission measurements
DPOAEs were measured with National Instruments (NI)
LabView 8.6 software installed on a PC. An NI PCI-4461
Dynamic Signal Analyzer (DSA) sound card and Clarion
SRU310H high frequency dome tweeters were used to de-
liver two pure tones into the outer ear canal of each
mouse. The two tones, f1 and f2, had a fixed f2/f1 ratio of
1.25 and presentation intensities of f2= f1- 10 dB. The f2
tones were varied from 5 kHz to 55 kHz over a range of
intensities (15 dB SPL to 85 dB SPL in 10 dB increments).
The amplitudes of the 2f1- f2 distortion products were
recorded along with the corresponding noise floor mea-
surements. All calculations performed on DPOAE were
performed on noise floor corrected amplitudes.
Analysis of DPOAE spectra
In order to extract pertinent information from the large
amount of data provided by the DPOAE measurements,
we analyzed the data in several ways. First, we reasoned
that good frequency discrimination might require
proximal portions of the organ of Corti to be more devel-
opmentally and functionally integrated than regions that
are more distal. Thus, we hypothesized that within a
particular strain, the intensity of the 2f1-f2 distortion
products would be more correlated for similar f1 frequen-
cies than for frequencies that were farther apart. To test
this, we calculated the correlation coefficients between the
2f1-f2 distortion products resulting from different 65 dB f2
tones and looked for patterns among the correlation
coefficients. Furthermore, we suspected that alleles that
affect hearing could alter the correlations between the
distortion products intensities produced in response to
stimuli of different frequencies, particularly if the genes
involved were frequency-specific. We hypothesized that
any alleles with frequency-specific effects would decrease
the correlations between the distortion products of the
affected cochlear regions and unaffected frequencies. To
evaluate this hypothesis, we compared the correlations
between all 2f1-f2 distortion products produced in
response to 65 dB intensity f2 inputs in the 4 parental lines
Keller and Noben-Trauth BMC Genetics 2012, 13:32 Page 12 of 14
http://www.biomedcentral.com/1471-2156/13/32and in the first generation (F1) offspring of the three
crosses. Finally, we performed Principal Component
Analysis (PCA) to determine which aspects of the
frequency spectra best differentiated between the indi-
viduals within each HFHL cross.
A substantial number of mice from the N2 and F2 popu-
lations had normal 32 kHz ABR thresholds but seemed to
exhibit abnormally high frequency DPOAE spectra. Since
hearing loss in HFHL mice appears to be related to OHC
function [10] and the neuronal activity recorded by ABR is
several physiological steps removed from OHC activity, we
reasoned that the DPOAE results might provide a better
quantitative measure for QTL analysis than the ABR
thresholds. Therefore, we evaluated the DPOAE curves in
order to devise a quantitative value that was amenable to
QTL analysis but reflected the readily observable
differences in DPOAE among mice in our populations.
Variability in noise level and random, bidirectional spikes
in the recorded 2f1-f2 distortion product intensities
precluded the determination of a clear frequency threshold
for an individual’s DPOAE. Similarly, the 2f1-f2 distortion
product intensity at any particular frequency was unten-
able as a meaningful quantitative measure of emission
quality for an individual. However, mice with normal
emissions could be differentiated from mice with impaired
emissions by comparing the 2f1-f2 distortion product
intensities generated over an isolated range of high
frequency (>30 kHz) f2 inputs of high intensity. Since
mice with hearing thresholds greater than 60 dB SPL are
generally considered to be hearing-impaired, we chose to
use the results of the 65 dB f2 stimulus intensity. For each
mouse, we averaged the noise-floor corrected 2f1-f2 inten-
sities produced over the range of frequencies (30–44 kHz)
with the most conspicuous difference between individuals.
These High Frequency Emissions Averages (HFEA) served
as a quantitative measure of the quality of an individual’s
DPOAE.
To further dissect and summarize the DPOAE data
and to produce less subjective quantitative values that
were appropriate for linkage mapping, we calculated
principal components for the 2f1-f2 distortion product
intensities from the three crosses. Principal components
analysis converts a correlation matrix into a smaller set
of orthogonal values (the principal components) that
best describe the patterns in the original data [26]. In
this analysis, we used the first three principal compo-
nents (PC1-3) as additional quantitative traits for QTL
analysis in each population.
We also reasoned that since OHC physiology and
activity mirror the frequency gradient of the cochlea,
our DPOAE data might provide us with an opportunity
to discover some of the loci involved in producing basal
to apical differences in cochlear properties. We hypothe-
sized that if frequency-specific differences in hearingresult from different genes being active in different
regions of the cochlea, then different loci (QTL) would
be detected for different frequency ranges. Therefore, we
divided the DPOAE frequency spectra into 5 kHz
segments (5–9 kHz, 10–14 kHz, 15–19 kHz, 20–
24 kHz, 25–29 kHz, 30–34 kHz, 35–39 kHz, 40–
44 kHz, 45–49 kHz, and 50–55 kHz), obtained noise
floor corrected average DPOAE values for each of these
segments, and used each of these averages as a quantita-
tive trait for mapping QTL.
Genetic analysis
DNA was extracted from tail clips using DNeasyW Blood
and Tissue kits (Qiagen, Valencia, CA). Samples from
C3H-N2 mice were adjusted to approximately 100 ng/μl
(40–130 ng/μl) for genome-wide genotyping at The Part-
ners Center for Personalized Genetic Medicine (Cam-
bridge, MA). These C3H-N2 mice and randomly
selected P0 and F1 mice were genotyped at 337 SNPs
(single nuceotide polymorphisms) spaced an average of
6.5 Mb apart. Of these 337 SNPs, 145 were useful in our
analysis. Aliquots from the C3H-N2 samples and DNA
samples from CBA-F2 and C57-F2 mice were diluted to
approximately 10 ng/μl (1–20 ng/μl) for additional geno-
typing using TaqManW SNP Genotyping Assays with a
StepOnePlus Real-Time PCR Thermocycler (Applied
Biosystems). For genomic regions where the available
TaqManW SNP Genotyping Assays were not suitable for
genotyping a particular cross, mice were genotyped at
microsatellites for which the two parental strains were
found to be polymorphic. For microsatellite genotyping,
the microsatellite regions of the DNA samples were
amplified via PCR with AmpliTaqW DNA Polymerase
(Applied Biosystems) mixed with standard concentra-
tions of dNTP, 10x PCR reaction buffer, and forward and
reverse primers in molecular biology grade water. For
PCR amplification, samples were denatured (95°C for
1 min), then subjected to 50 cycles consisting of denatur-
ation (94°C for 45 s), annealing (55°C for 1 min), and ex-
tension (72°C for 1 min), followed by a final extension step
(72°C for 10 min). For genotype determination, 1 μl of
each PCR reaction was mixed with 8.9 μl of formamide
and 0.1 μl of GeneScanTM 500ROXTM size standard and
electrophoresed on a 3730xl capillary DNA analyzer
(Applied Biosystems). Data were analyzed using ABITM
Prism GeneMapperTM v 3.5 software. For F2 individuals
for which the two homozygous genotypes were difficult to
distinguish from the electropherograms, a second run was
performed on each homozygote using a mix consisting of
equal concentrations of the sample DNA and DNA from
one of the parental strains. If this second run resulted in a
homozygous genotype, the sample was declared to possess
the same genotype as the parental strain used in the mix.
If the second run resulted in a heterozygous genotype, the
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parental strain’s genotype.
QTL analysis
Previously, we performed a whole-genome QTL analysis
using the ABR thresholds obtained from approximately
300 C3H-N2 mice when they were 8 weeks old [10]. To
more fully explore the genetics underlying high-frequency
hearing loss, the same mice were used in this study to
identify QTL that significantly affect DPOAE. Genotypes
at 145 SNPs and the corresponding DPOAE measures
(PC1-3, HFEA, and averages obtained for each 5 kHz
segment of the 65 dB frequency spectra) for each mouse
were imported into Map Manager QTXb20. Map Manager
QTXb20 was used to perform least-squares linear regres-
sions and generate LRS (likelihood ratio statistic) scores
[27]. 1000 permutations of the data were generated and
evaluated by linear regression to establish significance
thresholds for the LRS scores generated by the analysis
[28]. LRS scores greater than 37, 95, or 99.9% of the
permutation-derived values (equivalent to genome-wide p
values of 0.63, 0.05, and 0.001) were considered suggestive,
significant, or highly significant evidence of QTL, respect-
ively [29]. LRS scores were converted to LOD scores (LRS/
2ln(10) = LOD) by dividing by 4.61.
We next performed composite interval mapping on each
chromosome for which a putative QTL was detected in the
marker regression analysis. This allowed us to more accur-
ately estimate the locations of the QTL and to determine
support intervals [30]. We included the most significant
unlinked QTL from the marker regressions as background
loci in each of these analyses. Furthermore, we tested for
associations between each trait and each pair of marker
loci to identify potential gene interactions (i.e. epistatic
effects). We only considered interactions significant if the
effect of the combined loci were significant at the p=10-5
level and the interaction effect was also significant at the
permutation derived p=0.01 level.
We performed a similar linkage analyses for our CBA-F2
and C57-F2 populations. Significance thresholds for these
analyses were obtained using permutation tests and via the
“Quick Test” option of QTXb20. The more stringent
threshold value of the two calculated for each trait was
selected as the actual threshold value. Since only a portion
of the genome was mapped, we did not calculate signifi-
cance levels for suggestive QTL. Threshold values
exceeding the p=0.05 threshold value were considered
evidence of a QTL and those exceeding p= 0.001 were
considered highly significant. Furthermore, 32 kHz ABR
thresholds were included in the phenotypic data, but the
genotypic data was limited to SNPs located in regions that
had already been putatively identified as containing QTL
or suggestive QTL in our original analysis or in the current
analysis of the C3H-N2 population. SNPs all alongchromosome 10 were also genotyped so that any effects of
Cdh23 mutations could be eliminated and potential
interactions with chromosome 10 loci could be evaluated.
ABR thresholds were included for comparison to the
C3H-N2 results obtained previously. The loci genotyped
in the C57-F2 and CBA-F2 populations are listed on
Table 3, along with their locations and the closest
corresponding loci genotyped in the C3H-N2 population.Statistical analyses
Differences between groups were assessed by one-way
ANOVA followed by Bonferroni corrected post-tests after
determining that they had equal variances and Gaussian
distributions. For comparisons between groups that failed
to meet the requirements of ANOVA, Kruskal-Wallis tests
with post-tests were performed. GraphPad Prism 4.0b
software was used to calculate means, plot the data, and
compute p values for the comparisons.
Correlation coefficients and PCs were calculated using
the multivariate option of JMPTM Software version 5.0.1.2
from SAS Institute. Pearson Product–moment Correlation
coefficients were tested for significance using the Pairwise
Correlations option. Because we expected the 2f1-f2
distortion product amplitudes to be positively correlated,
we used one-tailed tests to assess the significance of these
correlations. However, since many correlations were
evaluated in each population and a proportion of these
correlations (10%) are expected to be significant simply
due to chance, we used χ2 tests to determine whether or
not the proportion of significant correlations was greater
than expected due to chance.Description of additional data files
The following additional data are available with the on-
line version of this paper. Additional data file 1–4 are
tables of the correlation coefficients between the 2f1-f2
distortion products resulting from different 65 dB f2
tones in the HFHL line, the C3HeB/FeJ, the CBA/CaJ,
and the C57BL/6J strains.Additional files
Additional file 1: Table S1. Correlations between 2f1-f2 emissions
intensities produced in response to different f2 input frequencies in the
HFHL line. Bold values are significant.
Additional file 2: Table S2. Correlations between 2f1-f2 emissions
intensities produced in response to different f2 input frequencies in the
C3HeB/FeJ strain. Bold values are significant.
Additional file 3: Table S3. Correlations between 2f1-f2 emissions
intensities produced in response to different f2 input frequencies in the
CBA/CaJ strain. Bold values are significant.
Additional file 4: Table S4. Correlations between 2f1-f2 emissions
intensities produced in response to different f2 input frequencies in the
C57BL/6J strain. Bold values are significant.
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